Henderson Jane bought AKRO
August 12, 2025 · Form 4 insider transaction
Henderson Jane bought 3,000 shares of Akero Therapeutics, Inc. at $7.01 per share, a transaction worth $21.0K. The trade was recorded as option exercise and disclosed on an SEC Form 4, filed 0 days after the transaction.
Direction
Acquired (buy-side)
Shares
3,000
Price
$7.01
Total value
$21.0K
InsiderHenderson Jane
RoleOfficer, Director
SecurityCommon Stock
Transaction codeM: Option exercise
Transaction dateAugust 12, 2025
Filing dateAugust 12, 2025
Shares owned after12,398
OwnershipDirect
10b5-1 planNo
AmendedNo